Plasma CellsMultiple MyelomaBone Marrow CellsBone MarrowParaproteinemiasHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningPrognosisFlow CytometryTransplantation, AutologousParaproteinsB-LymphocytesHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationBone and BonesHematopoietic Stem CellsTransplantation ChimeraStem CellsAmyloidosisBusulfanTissue DonorsTreatment OutcomeGraft vs Leukemia EffectRemission InductionMyeloablative AgonistsRecurrenceLeukemiaGraft SurvivalGraft vs Tumor EffectVidarabineWhole-Body IrradiationLeukemia, Myeloid, AcuteHistocompatibility TestingLymphocyte TransfusionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesImmunosuppressive AgentsCell DifferentiationBone Marrow DiseasesCombined Modality TherapyHematopoiesisRetrospective StudiesTime FactorsLymphocyte DepletionBone Marrow ExaminationAntigens, CD34Mice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsBone RemodelingAnemia, AplasticHistocompatibilityT-LymphocytesCord Blood Stem Cell TransplantationSurvival AnalysisNeoplasm, ResidualDisease-Free SurvivalSiblingsCells, CulturedMinor Histocompatibility AntigensSalvage TherapySurvival RateCyclophosphamideAntilymphocyte SerumBone Marrow NeoplasmsMelphalanColony-Forming Units AssayLiver TransplantationMesenchymal Stem Cell TransplantationHematopoietic Stem Cell MobilizationChimerismVirus ActivationLeukemia, Plasma CellBone Marrow PurgingAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsPrimary MyelofibrosisLeukemia, MyeloidHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorHematologic DiseasesCell TransplantationRadiation ChimeraBone DensityCytomegalovirusFollow-Up StudiesBone ResorptionImmunosuppressionHLA AntigensTransplantation ImmunologyCytarabineAntibodies, MonoclonalCell SeparationImmunophenotypingAntigens, CDAntineoplastic Agents